Clinical trial
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are…
NCT00244920 · OHSU Knight Cancer Institute, Other · Withdrawn
Key facts
| NCT number | NCT00244920 |
|---|---|
| Title | Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer |
| Official title | An Open Label Randomized Phase 2 Study To Evaluate The Activity, Tolerability, And Toxicity Of Combined Neoadjuvant Anti-angiogenesis and Androgen Ablation Therapy in Men Undergoing Radical Prostatectomy |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | bicalutamide, leuprolide acetate, squalamine lactate, adjuvant therapy, antiandrogen therapy, antiangiogenesis therapy, conventional surgery, neoadjuvant therapy, releasing hormone agonist therapy |
| Enrollment | 0 |
| Start date | Jan 1, 2002 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Oct 27, 2005 |
| Last update posted | May 28, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: